22nd February 2022 | Pharma Updates
Intas Pharma to Market Clozapine
The drug is indicated for the treatment of adult patients with schizophrenia.
DCGI grants EUA to Corbevax for 12-18 yrs age group
The drugmaker has received a green signal for Corbevax from the Drugs Controller General of India for the 12 to 18 years age group.
Drug Regulator Accepts NDA for Poziotinib
A new drug application has been acknowledged by the United States Food and Drug Administration for poziotinib in patients with advanced or metastatic non–small cell lung cancer with HER2 exon 20 insertion mutations.
Abbott Gets FDA Nod to Market CARDIOMEMS™ HF SYSTEM
The device is designed to monitor pressure changes that indicate worsening heart failure.
FDA Okays TransThera’s Investigational New Drug application for B-Cell lymphoma Treatment
The United States Food and Drug Administration has given approval to TransThera Sciences’ Investigational New Drug application for TT-01488 to treat B-cell lymphomas.
Lennox buys Lab Equipment Firm
The company now plans to create 30 new jobs in the next two years.
Young Innovations purchases MPS
A leading dental products supplier has completed the acquisition of medical purchasing solutions.
Labcorp Acquires Personal Genome Diagnostics
As part of the agreement, Labcorp would pay USD 450 mn in cash at closing and around an additional US 125 mn later.
MJH Life Sciences Completes Acquisition of Cannabis Science Conference
MJH Life Sciences bought Cannabis Science Conference, which organizes bi-annual scientific and medical cannabis events.
Abbott Recalls Powdered Formula
The US’s drug regulator cited four consumer complaints related to Cronobackter sakazakii and Salmonella Newport in babies.